Clinical trial
A Two Year Study of the Clinical Efficacy of the Combination of Emtricitabine…
NCT00344461 · University of Maryland, Baltimore, Other · Completed
Key facts
| NCT number | NCT00344461 |
|---|---|
| Title | A Two Year Study of the Clinical Efficacy of the Combination of Emtricitabine, Tenofovir, and Nevirapine |
| Official title | Cell Cycle Independent Antiretroviral Therapy: Combination of Nevirapine, FTC, and Tenofovir |
| Lead sponsor | University of Maryland, Baltimore, Other |
| Collaborators | Boehringer Ingelheim Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV |
| Intervention type | Drug |
| Interventions | Nevirapine, FTC, and Tenofovir |
| Enrollment | 54 |
| Start date | Mar 1, 2004 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Jun 26, 2006 |
| Last update posted | Nov 1, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: